According to Mordor Intelligence, the global prefilled syringes market is experiencing strong expansion as healthcare systems increasingly prioritize safe, convenient, and accurate drug delivery ...

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

The Global Prefilled Syringes Market is expected to witness a high single-digit growth rate by 2027. The growth of the prefilled syringes market is driven by an increasing prevalence of diverse ...

SAN DIEGO, April 10, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART ® ...

Prefilled Syringes Market Prefilled Syringes Market Growth Rate By Region · GlobeNewswire Inc. Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Prefilled Syringes - Market Share Analysis, Industry ...

Credit: Fresenius Kabi. The 100mcg per 2mL presentation is offered in a manufacturer-prepared prefilled syringe. Fresenius Kabi has launched a 100mcg per 2mL presentation of Fentanyl Citrate Injection ...

– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects our ...

As part of a patient-support program (PSP) for those with neuroendocrine tumors (NETs), Ipsen offers Somatuline Autogel/Somatuline Depot (lanreotide) in a prefilled syringe. The company recently ...

According to Mordor Intelligence, the global prefilled syringes market is experiencing strong expansion as healthcare systems increasingly prioritize ...